Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $833.7450 (0.23%) ($833.7450 - $833.7450) on Tue. Oct. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.18% (three month average) | RSI | 50 | Latest Price | $833.7450(0.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 0.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(66%) IBB(61%) DIA(56%) XLF(56%) SPY(53%) | Factors Impacting REGN price | REGN will decline at least -0.59% in a week (0% probabilities). VXX(-47%) VIXM(-41%) TBT(-25%) USO(-20%) GLD(-12%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.59% (StdDev 1.18%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $829.86(0.47%) | 10 Day Moving Average | $826.73(0.85%) | 20 Day Moving Average | $827.81(0.72%) | To recent high | -1.3% | To recent low | 18.7% | Market Cap | $88.401b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |